Karyopharm Therapeutics Inc. (KPTI) — DEF 14A Filings
All DEF 14A filings from Karyopharm Therapeutics Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
- DEF 14A Filing — Apr 14, 2025
-
Karyopharm Therapeutics Sets 2025 Shareholder Meeting
— Dec 16, 2024 Risk: low
Karyopharm Therapeutics Inc. filed its definitive proxy statement for its 2025 annual meeting of stockholders, scheduled for January 30, 2025. The filing, made -
Karyopharm Therapeutics Inc. Files Definitive Proxy Statement
— Apr 19, 2024 Risk: low
Karyopharm Therapeutics Inc. (KPTI) filed a Proxy Statement (DEF 14A) with the SEC on April 19, 2024. Karyopharm Therapeutics Inc. filed a Definitive Proxy Stat
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX